Six procedures are moved from hospital to out-patient settings in Switzerland

16

Apr 2018

There are more in-patient surgical interventions performed in Switzerland compared with other European countries, even when an outpatient intervention would be appropriate from a medical point of view, in the interest of the patient and would require fewer resources.

The DFI decided that the six groups of interventions will be reimbursed only if performed in out-patient settings. The list has been drafted on October 4th, 2017, on the amendment of Annex 1 of the Insurance Benefits Ordinance. These are the groups of interventions (with CHOP 2017 codes):

  • Unilateral interventions on varicose veins of the legs (Z38.5);

- Interventions on haemorrhoids (Z49.4);

- Unilateral interventions of an inguinal hernia (Z53);

- Explorations/surgeries on the cervix or uterus (Z67);

- Arthroscopy of the knee, including arthroscopic operations on the meniscus (Z80.26);

  • Surgeries on tonsils and adenoids (Z28.2).

The Federal Office of Public Health (FOPH) has instructed the Swiss Health Observatory (OBSAN) to perform an analysis for selection of surgical procedures, and that is how the six groups of interventions have been chosen. The OBSAN has come up to a conclusion that the Cantons will save the most, more than 90 million CHF.

This change will come into force starting January 1st, 2019. The transition period will allow hospitals and insurers to adapt to the new organizational regulation. At the moment, derogatory criteria are also drawn upon the basis of which it will be possible to reimburse even the stationary treatments.

See the full report in Italian here (you can change to German or French in the top-right corner).

See the full list of procedures in Italian here and in German here.

See the analysis by OBSAN in French (with German summary) here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more